US FDA Neuroscience Office Director Billy Dunn Departs As Agency Faces New Review Challenges

 
• By Sue Sutter
  
Door handle
FDA's Billy Dunn is closing the door on an 18-year career at the agency. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership